| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |